Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Actolac
- Development stage
- Unknown
- Lead developer
- Thrift Pharmaceuticals
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Actolac is a multi-ingredient oral formulation developed by Thrift Pharmaceuticals, available as tablets and an oral suspension. It is designed to support gastrointestinal health and aid digestion. The formulation combines probiotics (Lactic Acid Bacillus) to restore and maintain healthy intestinal microflora, digestive enzymes (Diastase and Papain) to facilitate the breakdown of carbohydrates and proteins, and an antiflatulent (Simethicone) to alleviate gas and bloating. Additionally, it contains Zinc Sulphate, Folic Acid, and a multivitamin complex to provide essential nutritional support and aid in recovery from gastrointestinal disturbances such as diarrhea and indigestion.
- Brand names
- Actolac
Beyond the preview
Go deeper on Actolac.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Actolac.